Acknowledgements This project was supported by funds from the National Key Research and Development Programme of China to TW under grant number (2023YFD1400300), the National Natural Science Foundation of China to TW under grant number U23A20197 and 31920103014, the Natural Science Foundation of Fujian Province to HC under grant number 2021J01065
But semaglutide is not a magic solution, and the information landscape surrounding it ranges from overly optimistic to unnecessarily alarming
Tirzepatide was originally approved by the FDA in 2022 under the brand name Mounjaro to help control blood sugar in Type 2 diabetes
Weight-regulation hormones can remain altered for at least 12 months after major loss, so a single treatment cycle may not cover the full biological adaptation. Mechanism "GLP-3" is an informal count of retatrutides three receptors, not a drug class
Carbohydrates can be adjusted based on activity level and personal response
The pill is one of two oral GLP-1 drugs expected to enter the market soon